Teva Pharmaceutical Industries ROA - Return on Assets 2010-2024 | TEVA

Teva Pharmaceutical Industries return on assets for the quarter ending September 30, 2024 was -2.26.

  • Teva Pharmaceutical Industries average return on assets for 2023 was -3.99, a 36.18% decline from 2022.
  • Teva Pharmaceutical Industries average return on assets for 2022 was -2.93, a 12.28% increase from 2021.
  • Teva Pharmaceutical Industries average return on assets for 2021 was -3.34, a 18.54% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Teva Pharmaceutical Industries ROA - Return on Assets 2010-2024 | TEVA

  • Teva Pharmaceutical Industries average return on assets for 2023 was -3.99, a 36.18% decline from 2022.
  • Teva Pharmaceutical Industries average return on assets for 2022 was -2.93, a 12.28% increase from 2021.
  • Teva Pharmaceutical Industries average return on assets for 2021 was -3.34, a 18.54% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M